Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications

After the publication of the article, the authors retrospectively noted that the name of Dr Dawn Jones, a postdoctoral researcher in the laboratory of Professor Christine Gosden, should have been added to the authors' list, whose contribution to the study greatly augmented the exploration of all the RNA products via adoption of the RNASeq (Illumina) methodology. All the existing authors agree to the inclusion of Dr Jones as a co‑author, with the exception of Derek Gardener, who has retired from the Institute and is no longer contactable by e-mail (although we are confident that he would not raise any objection). The correct author list (and affiliations) should therefore have been published as follows: Shiva Seyed Forootan1, Joe M. Butler1, Derek Gardener1, Dawn Jones1, Alison E. Baird1, Andrew Dodson1, Alistair Darby2, John Kenny2, Neil Hall2, Andrew R. Cossins2, Christopher S. Foster1,3 and Christine M. Gosden1 1Molecular Pathology Laboratory, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Royal Liverpool University Hospital, Liverpool L69 3GA; 2Center for Genomic Research, University of Liverpool, Liverpool L69 7ZB; 3HCA International, Pathology Laboratories, London WC1E 6JA, UK. We regret the oversight of having failed to include Dr Dawn Jones as an author on this paper. [the original article was published in the International Journal of Oncology 48: 130-144, 2016; DOI: 10.3892/ijo.2015.3222].